A Pilot Study of Cetuximab and the Hedgehog Inhibitor Ipi-926 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Daniel W. Bowles,Stephen B. Keysar,Justin R. Eagles,Guoliang Wang,Magdalena J. Glogowska,Jessica D. McDermott,Phuong N. Le,Dexiang Gao,Charles E. Ray,Paul J. Rochon,Dennis R. Roop,Aik-Choon Tan,Hilary S. Serracino,Antonio Jimeno

Oral oncology（2016）

Cited 29|Views32
No score
Key words
Hedgehog signaling pathway,Phase 1,Cetuximab,Combination therapy,Head and neck squamous cell carcinoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined